Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells [Retraction]
Cheng M, Xu H, Wang Y, et al. Drug Des Devel Ther. 2013;7:1287–1299. It has come to the notice of this journal that the published paper:Cheng M, Xu H, Wang Y, et al. Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer mo...
Saved in:
Main Authors: | Cheng M (Author), Xu H (Author), Wang Y (Author), Chen H (Author), He B (Author), Gao X (Author), Li Y (Author), Han J (Author), Zhang Z (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2014-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells
by: Cheng M, et al.
Published: (2013) -
A Novel Glycyrrhetinic Acid-Modified Oxaliplatin Liposome for Liver-Targeting and in vitro/vivo Evaluation [Retraction]
by: Chen J, et al.
Published: (2022) -
A novel glycyrrhetinic acid-modified oxaliplatin liposome for liver-targeting and in vitro/vivo evaluation
by: Chen J, et al.
Published: (2015) -
Study on fluorouracil-chitosan nanoparticle preparation and its antitumor effect
by: Gaimin Chen, et al.
Published: (2016) -
Preparation of 5-fluorouracil-loaded chitosan nanoparticles and study of the sustained release in vitro and in vivo
by: Li Sun, et al.
Published: (2017)